| pubmed-article:18185136 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C0042164 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C0271051 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:18185136 | lifeskim:mentions | umls-concept:C1135130 | lld:lifeskim |
| pubmed-article:18185136 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18185136 | pubmed:dateCreated | 2008-1-10 | lld:pubmed |
| pubmed-article:18185136 | pubmed:abstractText | : Bevacizumab is a monoclonal antibody to vascular endothelial growth factor (VEGF) which has been successfully used for the treatment of age-related macular degeneration with choroidal neovascularization. As VEGF is involved in the pathomechanisms of inflammation and endothelial dysfunction the authors used bevacizumab as a last resort treatment in patients with persistent uveitic cystoid macular edema (CME). | lld:pubmed |
| pubmed-article:18185136 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18185136 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18185136 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18185136 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18185136 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18185136 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18185136 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18185136 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18185136 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18185136 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:18185136 | pubmed:issn | 0275-004X | lld:pubmed |
| pubmed-article:18185136 | pubmed:author | pubmed-author:HeiligenhausA... | lld:pubmed |
| pubmed-article:18185136 | pubmed:author | pubmed-author:HeinzCarstenC | lld:pubmed |
| pubmed-article:18185136 | pubmed:author | pubmed-author:BeckerMatthia... | lld:pubmed |
| pubmed-article:18185136 | pubmed:author | pubmed-author:MackensenFrie... | lld:pubmed |
| pubmed-article:18185136 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18185136 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:18185136 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18185136 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18185136 | pubmed:pagination | 41-5 | lld:pubmed |
| pubmed-article:18185136 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:meshHeading | pubmed-meshheading:18185136... | lld:pubmed |
| pubmed-article:18185136 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18185136 | pubmed:articleTitle | Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study. | lld:pubmed |
| pubmed-article:18185136 | pubmed:affiliation | Interdisciplinary Uveitis Center, Department of Ophthalmology, University of Heidelberg, Germany. friederike.mackensen@uveitiszentrum.de | lld:pubmed |
| pubmed-article:18185136 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18185136 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18185136 | lld:pubmed |
